Skip to content
All peptides
Research vial labelled Epithalon, a Mitochondrial and metabolic peptide studied in preclinical and clinical literature

Epithalon

Epitalon

Russian-language literature on pineal peptide bioregulators and telomerase activity.

Telomerase claims trace to a small number of ageing Russian studies that have never been independently replicated.

General profile

Class
Mitochondrial and metabolic
Evidence
Early or preclinical only
Studied dose range
5–10 mg
Frequency in protocols
Daily for 10 to 20 day courses
Route
Subcutaneous
Half life
Minutes
Reconstitution
2 mL bacteriostatic water per 10 mg vial
Storage
Refrigerated, ~30 days

Timing and cycling in the literature

Usually dosed in the bedtime window

Daily for 10 to 20 day courses

The Russian protocols run short nightly courses two or three times a year rather than continuous use, tied to pineal signalling.

Reported cycle: 3 weeks on, 20 weeks off

The Russian protocols are ten to twenty day courses repeated two or three times a year, not continuous dosing.

Watch for: Very little is documented, which is itself the thing to note.

What it conflicts with

Three separate questions, kept separate. A hard stop means the mechanisms must not run together at all and timing does not fix it. A syringe rule means the same day is fine but one barrel is not. Redundancy is not dangerous, it is paying twice to hit one target.

No named pair conflicts are on file for this compound. That is missing data, not clearance: with no compatibility data the default is separate syringes, and you still introduce one new compound at a time.

Most syringe compatibility claims here are practice and expert consensus, not peer reviewed mixing studies. A clear liquid after mixing does not prove the compounds are still active, and cloudiness, particles or gelling means discard. Active cancer, pregnancy, major cardiac care and heavy immunosuppression override every stack preference on this page.

See how Epithalon fits your week

The injection scheduler spaces doses using the clinical timing data, flags the pairs above before you draw them, and tells you why.

Model this in the injection scheduler

The studies

Human trials: Older Russian clinical reports that have not been replicated to modern standards.

Open questions: Methodology and reporting from the original studies are difficult to verify independently.

Published papers

Indexed from Europe PMC and refreshed weekly. Each link opens the paper itself.

Search the full literature